Literature DB >> 27284443

Prognostic significance of positive lymph node number in early cervical cancer.

Jung-Woo Park1, Jong Woon Bae1.   

Abstract

The aim of the present study was to investigate whether the number of metastatic lymph nodes (LNs) is an independent prognostic factor for early cervical cancer. The medical records of 163 stage IB-IIA cervical cancer patients, treated with radical hysterectomy with accompanying pelvic and/or para-aortic lymphadenectomy between 1999 and 2007, were retrospectively reviewed. All prognostic factors identified as being significant in the univariate analysis were included in the multivariate analysis using the Cox proportional hazards model. Of the 156 patients included in our analysis, 27 had LN metastasis, of whom 14 patients had 1 positive node and 13 patients had ≥2 positive nodes. The 5-year overall survival (OS) and progression-free survival (PFS) rates were 92.9 and 87.2%, respectively. In terms of OS, tumour stage (P=0.002) and the number of positive LNs (P=0.021) were identified as significant prognostic factors. In terms of PFS, tumour stage (P=0.049) was identified as a significant prognostic factor. In conclusion, the number of LN metastases is an independent risk factor for poorer survival outcomes in patients with cervical cancer.

Entities:  

Keywords:  early cervical cancer; lymph nodes number; prognostic factors

Year:  2016        PMID: 27284443      PMCID: PMC4887882          DOI: 10.3892/mco.2016.837

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  21 in total

1.  Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Authors:  M A Quinn; J L Benedet; F Odicino; P Maisonneuve; U Beller; W T Creasman; A P M Heintz; H Y S Ngan; S Pecorelli
Journal:  Int J Gynaecol Obstet       Date:  2006-11       Impact factor: 3.561

2.  Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium.

Authors:  Sergio Pecorelli
Journal:  Int J Gynaecol Obstet       Date:  2009-05       Impact factor: 3.561

3.  The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB.

Authors:  T Inoue; K Morita
Journal:  Cancer       Date:  1990-05-01       Impact factor: 6.860

4.  Prognostic factors and impacts of adjuvant therapy in early-stage cervical carcinoma with pelvic node metastases.

Authors:  C H Lai; H C Chang; T C Chang; S Hsueh; S G Tang
Journal:  Gynecol Oncol       Date:  1993-12       Impact factor: 5.482

5.  Close vaginal margins as a prognostic factor after radical hysterectomy.

Authors:  R E Estape; R Angioli; M Madrigal; M Janicek; C Gomez; M Penalver; H Averette
Journal:  Gynecol Oncol       Date:  1998-03       Impact factor: 5.482

6.  High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.

Authors:  Y Aoki; M Sasaki; M Watanabe; T Sato; I Tsuneki; H Aida; K Tanaka
Journal:  Gynecol Oncol       Date:  2000-05       Impact factor: 5.482

7.  Parametrial involvement, regardless of nodal status: a poor prognostic factor for cervical cancer.

Authors:  T G Zreik; J T Chambers; S K Chambers
Journal:  Obstet Gynecol       Date:  1996-05       Impact factor: 7.661

8.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.

Authors:  W A Peters; P Y Liu; R J Barrett; R J Stock; B J Monk; J S Berek; L Souhami; P Grigsby; W Gordon; D S Alberts
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

9.  Patterns of treatment failure following radiotherapy with combination chemotherapy for patients with high-risk stage IIB cervical carcinoma.

Authors:  Tchan-Kyu Park; Ja-Young Kwon; Sang-Wun Kim; Sung-Hoon Kim; Soo-Nyung Kim; Gwi Eon Kim
Journal:  Int J Clin Oncol       Date:  2004-04       Impact factor: 3.402

10.  The global burden of cancer: priorities for prevention.

Authors:  Michael J Thun; John Oliver DeLancey; Melissa M Center; Ahmedin Jemal; Elizabeth M Ward
Journal:  Carcinogenesis       Date:  2009-11-24       Impact factor: 4.944

View more
  5 in total

1.  Whether individualized dose escalation should be recommended for lymph nodes with different sizes in the definitive radiotherapy of cervical cancer?

Authors:  Xiaojuan Lv; Huiting Rao; Tao Feng; Chufan Wu; Hanmei Lou
Journal:  Radiat Oncol       Date:  2022-10-20       Impact factor: 4.309

2.  Monocytosis as a prognostic factor for survival in stage IB and IIA cervical cancer.

Authors:  Wan Kyu Eo; Byung Su Kwon; Ki Hyung Kim; Heung Yeol Kim; Hong-Bae Kim; Suk Bong Koh; Sungwook Chun; Yong Il Ji; Ji Young Lee; Jeong Namkung; Sanghoon Kwon
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

Review 3.  Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review.

Authors:  Fengying Qin; Huiting Pang; Tao Yu; Yahong Luo; Yue Dong
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

4.  Should the Number of Metastatic Pelvic Lymph Nodes be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer?

Authors:  Luigi Pedone Anchora; Vittoria Carbone; Valerio Gallotta; Francesco Fanfani; Francesco Cosentino; Luigi Carlo Turco; Camilla Fedele; Nicolò Bizzarri; Giovanni Scambia; Gabriella Ferrandina
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

5.  UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study.

Authors:  Hideki Matsuoka; Ryusuke Murakami; Kaoru Abiko; Ken Yamaguchi; Akihito Horie; Junzo Hamanishi; Tsukasa Baba; Masaki Mandai
Journal:  BMC Cancer       Date:  2020-08-05       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.